Evidence map›Paper›PMID 41272607›Full record

ArticleBMC musculoskeletal disorders2025

Comprehensiveness and validity of a multidimensional assessment of patients with fibromyalgia: a prospective cohort study.

Thomas Benz, Susanne Lehmann, Peter S Sandor, Felix Angst

Abstract readValidation Study
In one paragraph

Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thomas BenzResearch Department, Rehaklinik Bad Zurzach, ZURZACH Care Group, Quellenstrasse 34, Bad Zurzach, 5330, Switzerland. thomas.benz@zurzachcare.ch.
Susanne LehmannResearch Department, Rehaklinik Bad Zurzach, ZURZACH Care Group, Quellenstrasse 34, Bad Zurzach, 5330, Switzerland.
Peter S SandorResearch Department, Rehaklinik Bad Zurzach, ZURZACH Care Group, Quellenstrasse 34, Bad Zurzach, 5330, Switzerland.
Felix AngstResearch Department, Rehaklinik Bad Zurzach, ZURZACH Care Group, Quellenstrasse 34, Bad Zurzach, 5330, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFibromyalgia is a complex syndrome affecting all dimensions of biopsychosocial health and quality-of-life. The aim of the study was to quantify the cross-sectional and longitudinal validity of single measurement scales in specific construct domains and to examine how they combine to build a comprehensive, multidimensional outcome assessment of fibromyalgia before and after a standardized interdisciplinary pain program.

methodsThis prospective cohort study assessed 123 patients using 8 measures: the Short Form 36 (SF-36), the Multidimensional Pain Inventory (MPI), the Symptom Checklist-90-Revised (SCL-90-R), the Quantification Inventory for Somatoform Syndromes (QUISS), the Fibromyalgia Health Assessment Questionnaire (FHAQ), the Fibromyalgia Impact Questionnaire (FIQ), the Coping Strategy Questionnaire (CSQ), and the 6-Minute Walking Distance (6MWD). The comprehensiveness of the constructs and their overlap were quantified cross-sectionally and longitudinally by bivariate correlations, explorative factor analysis, and effect sizes (ESs).

resultsThe mean age of the participants was 48.6 years (+/-9.8); 86.2% were female. Factor analysis revealed 2 factors with a totally explained variance of 44.5%-64.5%. At the baseline and follow-up cross-sectional analyses, mental health and psychosocial factors loaded more strongly on the first, mental health factor, especially the 4 SCL-90-R scales (factor loads 0.75-0.90) than on the second, predominantly physical function factor. Longitudinally (score differences), the predominantly physical function factor was dominant, with loads of 0.61 (FHAQ), 0.66 (6MWD), and SF-36 and MPI pain (0.68 each). Maximum cross-sectional correlations were up to 0.89 between depression and anxiety, up to 0.87 between pain and interference on the MPI (0.79 longitudinally), and up to 0.83 between depression and catastrophizing. Longitudinally all scales showed improvements. The greatest effects were measured on MPI Pain severity (ES = 0.78) and Interference (0.71).

conclusionsAll 23 health parameters examined had moderate to high factor loads on at least one factor, evidence of the multidimensionality of fibromyalgia. Mental health and function explained the substantial, partially comparable variances of the clinical characteristics. Both domains are almost equally important in describing the syndrome. An accurate description of fibromyalgia requires comprehensive assessment of a broad spectrum of constructs, including fatigue, somatization and coping strategies, particularly catastrophizing, in addition to the traditional pain, function and mental health.

Indexed as

FibromyalgiaPain MeasurementAdultCohort StudiesCross-Sectional StudiesFemaleHumansLongitudinal StudiesMaleMiddle AgedProspective StudiesQuality of LifeReproducibility of ResultsSurveys and QuestionnairesFibromyalgiaOutcome assessmentPatient outcome measurementPhysical functional performanceReproducibility of results

Identifiers

PMID41272607
PMCPMC12639793

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.